Engage Bio YC 申请

Winter 2022Acquired

Engage Bio 在 Winter 2022 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Winter 2022
行业: HealthcareTherapeutics
团队规模: 10
状态: Acquired
已发布: 2022

创始人

Will OlsenFounder

Engage Bio 做什么

Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.

Engage Bio 的 YC 申请，重建版

Y Combinator 申请

Engage Bio，Winter 2022 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Engage Bio

Describe what your company does in 50 characters or less.

Non-viral durable genetic medicines

What is your company going to make? Please describe your product and what it does or will do.

We make Tethosomes, a new class of non-viral DNA vehicle for genetic medicine. It delivers DNA potently, durably, and can be redosed safely, enabling scalable genetic therapies without the risks of viral vectors.

Where do you live now, and where would the company be based after YC?

We live and work in San Francisco, CA and would keep the company based here after YC.

Explain your decision regarding location.

San Francisco is where our team and biotech resources are located. It's the best place for access to talent and partnerships in healthcare and therapeutics.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Engage Bio 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Engage Bio 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Engage Bio 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Engage Bio 是哪个 YC 批次的？

Engage Bio 是 Y Combinator Winter 2022 批次的成员。

谁创立了 Engage Bio？

Engage Bio 由 Will Olsen 创立。

Engage Bio 做什么？

Potent, durable, and redosable non-viral genetic medicines

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 Engage Bio 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。